Funds backing therapeutics, drug discovery and life-science platforms, ranked by how many biotech companies they have actually funded.
Ranked by the number of biotech companies in each portfolio. Funds are included on the strength of deals they have actually done, not on how they describe themselves.
Y Combinator
acceleratorRA Capital Management
VCArch Venture Partners
VCArch Ventures
VCNovo Holdings
family_officeSofinnova Partners
VCGV Management Company, LLC
VCRA Capital Healthcare Fund
VCHBM Healthcare Investments
VCOrbiMed
VCHBM Healthcare
VCPerceptive Advisors
VCHBM Healthcare Investment
VCForbion
VCOrbiMed Israel Partners
VCNovo Holdings A/S
family_officeSOS Ventures
VCFlagship Pioneering
VCBoxer Capital
VCCatalio Capital Management
VCSofinnova Green Seed Fund
VCPolaris Ventures
VCSofinnova Venture Partners
VCPolaris Partners
VCSanofi Capital
VCCatalio Capital
VCHigh-Tech Gründerfonds
VCEcoR1 Capital
VCNextech
VCLife Science Partners (LSP)
VCNorthpond Ventures
VCEQT Ventures
VCViking Global Investors
VCNexTech Invest
VCCormorant Asset Management
VCDCVC
VCBain Capital Life Sciences
VCCasdin Capital
VCM-Ventures (Merck KGaA)
VCOxford Sciences Enterprises
VCAtlas Venture
VC5AM Ventures
VCo2h Ventures
VCSequoia Capital
VCAndreessen Horowitz Scout Fund
VCFidelity Investments
private_companyMorningside Ventures
VC2AM Ventures
VCPfizer Venture Investments
VCSOSV
acceleratorSofinnova
VCData Collective DCVC
VCUniversity of Oxford
institutionBoehringer Ingelheim Venture Fund GmbH
corporate_vcPontifax Capital
VCBI Invest
VCBoehringer Ingelheim Venture Fund (BIVF)
VCAndera Partners
VCUK Govt. Future Fund
VCSamsara BioCapital
VCSo you can judge whether it is trustworthy.
Every investor here has at least 2 portfolio companies tagged biotech. Membership is derived from the portfolio itself, so a fund appears because of the companies it backed rather than because its website lists biotech as a focus area.
Ranking is by number of biotech companies, then by total investment count. Counts move as new rounds are recorded, and a fund can appear in several sectors at once — most generalists do.